Providers
Latest News
July 31st 2025
Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
More News
The Structure of Risk Adjustment for Private Plans in Medicare
Health plan accounting data are used to test how well the CMSHCC risk adjustment system tracks relative costs of treating various diagnoses: not very well.
Read More
Identification of Patients Likely to Benefit From Care Management Programs
Three approaches to prospective patient identification for care management programs were compared: predictive modeling, selection by primary care physician, and a combination of both.
Read More
Do Economic Evaluations of Targeted Therapy Provide Support for Decision Makers?
May 17th 2011Economic evaluations of adjuvant trastuzumab were reviewed. Three primary shortcomings were identified including incorporation of local data and estimation and representation (visual) of decision uncertainty.
Read More
Health Plan Resource Use Bringing Us Closer to Value-Based Decisions
There is a critical need for comparative information about plan resource use to support value-based purchasing efforts.
Read More
